NCT03086915

Brief Summary

In retrospective data search the investigators will identified the percentage of patients with muscle relaxants administered during perioperative period. The block reversal, typ of drug, percentage of cases with and without reversal will be identified.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,650

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 5, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

March 5, 2017

Completed
17 days until next milestone

First Posted

Study publicly available on registry

March 22, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2017

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

November 19, 2018

Status Verified

November 1, 2018

Enrollment Period

5 months

First QC Date

March 5, 2017

Last Update Submit

November 16, 2018

Conditions

Neuromuscular Blockade

Keywords

neuromuscular blockademuscle relaxationmuscle relaxant

Outcome Measures

Primary Outcomes (1)

  • Percentage of neuromuscular block reversal

    The actual percentage of paediatric patients with perioperative neuromuscular blockade with active pharmacology block reversal at the end of surgery

    1 year

Secondary Outcomes (2)

  • Percentage of surgeries without muscle relaxant administration

    1 year

  • Type of neuromuscular blocking agent in paediatric anesthesiology practice

    1 year

Study Arms (1)

Patients with neuromuscular block

Neuromuscular blocking agent administrated during surgery to the paediatric patient

Drug: Neuromuscular Blocking Agent

Interventions

Neuromuscular Blocking AgentDRUG

Administration of neuromuscular blockers during anesthesia

Patients with neuromuscular block

Eligibility Criteria

AgeUp to 20 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Paediatric anesthesiology patients who underwent surgery with neuromuscular blocking agent administered during surgery in tertiary center paediatric anesthesiology department

You may qualify if:

  • paediatric patients
  • the study period (1/2016-12/2016)
  • neuromuscular blocking agent administration during surgery

You may not qualify if:

  • surgery without neuromuscular blockade

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brno University Hospital

Brno, 62500, Czechia

Location

MeSH Terms

Conditions

Muscle Hypotonia

Interventions

Neuromuscular Blocking Agents

Condition Hierarchy (Ancestors)

Neuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Neuromuscular AgentsPeripheral Nervous System AgentsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and Uses

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doc. MD. Ph.D

Study Record Dates

First Submitted

March 5, 2017

First Posted

March 22, 2017

Study Start

March 5, 2017

Primary Completion

July 30, 2017

Study Completion

August 1, 2017

Last Updated

November 19, 2018

Record last verified: 2018-11

Data Sharing

IPD Sharing
Will share

Locations

CZ(1)